12:00 AM
 | 
May 24, 1999
 |  BC Week In Review  |  Company News  |  Deals

Hyal, SkyePharma deal

SKP will acquire HYALF, including its 12 percent subordinated debentures, for $4.1 million in SKP stock, with $3.4 million worth of shares payable upon closing of the acquisition and the...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >